抗肿瘤治疗所致心脏疾病的研究进展
DOI: 10.3971/j.issn.1000-8578.2018.18.0993
Keywords: A Potential Biomarker for Lung Cancer,Challenges of Immune Checkpoint Inhibitors in Treatment of Non-small Cell Lung Cancer,Cardiotoxicity and Mechanisms of Immune Checkpoint Inhibitors,Research Progress of Biomarkers for Immunotherapy on Non-small Cell Lung Cancer,Cardiac Safety of Trastuzumab on 185 Patients with HER2 Positive Breast Cancer,Association of CYP1A1 and CYP1B1 Gene Polymorphisms with TypeⅠEndometrial Cancer in Chinese Women,Progress of Molecular Imaging-guided Tumor Immunotherapy,Metabonomics Investigation of Lung Adenocarcinoma in Male Patients Based on Liquid Chromatography-mass Spectrometry,Disease Characteristics of 3819 Lung Cancer Patients from 1985 to 2014 in Huangshi City of Hubei Province,Trends on Morbidity of Colorectal Cancer Among Residents in Xining City of Qinghai Province, 2009-2014,Multi-factors Affect Cardiac Toxicity in Radiotherapy on Left-sided Breast Cancer,Investigation of Dynamic Constituent Ratio Changes of Lung Cancer in Ningxia, 2000-2014,Application of Geographical Spatial Analysis in Cancer Epidemiology,Epidemiologic Investigation on Mortality Due to Esophagus Cancer in Residents in Xiamen, 2005-2014,Progress of Relationships of Calprotectin with Tumours
Abstract:
摘要 全球范围内，恶性肿瘤的发病率呈上升趋势，但随着治疗手段的进步，死亡率呈下降趋势。肿瘤患者的生存期及治疗周期延长，导致抗肿瘤治疗相关近期及远期不良反应的发生率显著增加。其中，尤以治疗相关心脏毒性日益引起人们的广泛关注。心脏损伤或既往心血管疾病加重等心血管事件的发生率甚至远高于恶性肿瘤的复发率。本文旨在对抗肿瘤治疗相关心脏疾病的研究现状及相关进展进行综述
Full-Text
